Cargando…

HER 2 immunohistochemistry for breast cancer cell blocks can be used in the same way as that used for histological specimens

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) testing of samples from recurrent or metastatic breast cancer is recommended by the 2013 update of the American Society of Clinical Oncology/College of American Pathologists guidelines. Although cytological analysis can be applied to severa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimura, Rieko, Okamoto, Nami, Satou, Masakazu, Kojima, Kenta, Tanaka, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819718/ https://www.ncbi.nlm.nih.gov/pubmed/26800514 http://dx.doi.org/10.1002/dc.23433

Ejemplares similares

Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections
por: Nishimura, Rieko, et al.
Publicado: (2016)

Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
por: Xu, Chen, et al.
Publicado: (2022)

Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay
por: Goud, Kalal Iravathy, et al.
Publicado: (2012)

Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation times
por: Kai, Keita, et al.
Publicado: (2019)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
por: Xu, Chen, et al.
Publicado: (2017)

Cell-blocks and immunohistochemistry
por: Shidham, Vinod B., et al.
Publicado: (2021)

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study
por: Matsui, Akira, et al.
Publicado: (2019)

Is HER2 amplification predictable by digital immunohistochemistry?
por: Micsik, Tamás, et al.
Publicado: (2013)

Principles of deep immunohistochemistry for 3D histology
por: Yau, Chun Ngo, et al.
Publicado: (2023)

Epidermal Growth Factor Receptor Gene Mutation Detection in Histology and Cytology Specimens of Primary Lung Adenocarcinoma: Immunohistochemistry Versus the Molecular Method
por: Abdul Hamid, Nurul Shuhada, et al.
Publicado: (2021)

Immunohistochemistry of Programmed Cell Death in Archival Human Pathology Specimens
por: Hasui, Kazuhisa, et al.
Publicado: (2012)

Cell‐blocks are suitable material for programmed cell death ligand‐1 immunohistochemistry: Comparison of cell‐blocks and matched surgical resection specimens in lung cancer
por: Pak, Min Gyoung, et al.
Publicado: (2019)

Combining Lipophilic dye, in situ Hybridization, Immunohistochemistry, and Histology
por: Duncan, Jeremy, et al.
Publicado: (2011)

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
por: Sandeck, Helmut P, et al.
Publicado: (2010)

Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
por: Juhlin, C. Christofer
Publicado: (2021)

Histological paraffin-embedded block: a good alternative specimen to detect the use of opiates at least 20 years ago
por: Di Candia, Domenico, et al.
Publicado: (2022)

Automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification using antibodies from the same species
por: Zhang, Wenjun, et al.
Publicado: (2015)

Are There More HER2 FISH in the Sea? An Institution’s Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
por: Suydam, Camille, et al.
Publicado: (2023)

Epithelium segmentation using deep learning in H&E-stained prostate specimens with immunohistochemistry as reference standard
por: Bulten, Wouter, et al.
Publicado: (2019)

Combined Use of Cell Block and Smear Improves the Cytological Diagnosis of Malignancy in Non-Palpable Breast Lesions Screened by Imaging
por: Nishimura, Rieko, et al.
Publicado: (2023)

Transforming growth factor-β in graft vessels: histology and immunohistochemistry
por: Yuan, Shi-Min, et al.
Publicado: (2011)

Grade Group accuracy is improved by extensive prostate biopsy sampling, but unrelated to prostatectomy specimen sampling or use of immunohistochemistry
por: Korpás, Kristóf Levente, et al.
Publicado: (2023)

Comprehensive Evaluation of PAXgene Fixation on Oral Cancer Tissues Using Routine Histology, Immunohistochemistry, and FTIR Microspectroscopy
por: Lahiri, Pooja, et al.
Publicado: (2021)

Objective quantification of nerves in immunohistochemistry specimens of thyroid cancer utilising deep learning
por: Astono, Indriani P., et al.
Publicado: (2022)

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
por: Morsberger, Laura, et al.
Publicado: (2022)

Blocking endogenous peroxidases: a cautionary note for immunohistochemistry
por: Radulescu, Razvan Tudor, et al.
Publicado: (2007)

Cytology and cell‐block immunohistochemistry of circulating tumour cells
por: Mayall, Frederick George, et al.
Publicado: (2019)

Diagnostic Accuracy of Cell Block and Immunohistochemistry in Effusion Cytology
por: Batool, Saima, et al.
Publicado: (2023)

Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics
por: Sugita, Shintaro, et al.
Publicado: (2016)

Conventional histological and cytological staining with simultaneous immunohistochemistry enabled by invisible chromogens
por: Morrison, Larry E., et al.
Publicado: (2021)

A decision tree-based prediction model for fluorescence in situ hybridization HER2 gene status in HER2 immunohistochemistry-2+ breast cancers: a 2538-case multicenter study on consecutive surgical specimens
por: Yang, Libo, et al.
Publicado: (2018)

Twenty Intracranial Skull Base Variations in the Same Specimen
por: Couldwell, Mitchell, et al.
Publicado: (2023)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Usefulness of immunohistochemistry in the diagnosis of hepatocolangiocarcinoma
por: Mora Morales, Estephani, et al.
Publicado: (2018)

Not All T Cell Synapses Are Built the Same Way
por: Kumari, Sudha, et al.
Publicado: (2019)

Multiple ways for the same destination: bone regeneration
por: Kim, Seong-Gon
Publicado: (2022)

HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor
por: Liu, Yuanyuan, et al.
Publicado: (2019)

Concordance between Histology, Immunohistochemistry, and RT-PCR in the Diagnosis of Feline Infectious Peritonitis
por: Stranieri, Angelica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mir5qld39vdlchcbrrjorhoqed